VEGFA and ablepharon macrostomia syndrome: This study fails to identify an increase in plasma VEGF levels in subjects with AMS; this finding echoes several other small studies that reached similar conclusions.[14–16] These human studies conducted at high altitudes have failed to reach a consensus regarding the role of VEGF in AMS and, further, whether VEGF levels do actually increase at high altitude.